Table 2 Characteristics of the study sample at baseline (that is, at the start of each 6-month intervention cycle)
|  | Total (n = 39) | Cycle 1 (n = 19) | Cycle 2 (n = 20) |
|---|---|---|---|
Mean (Standard Deviation) or absolute number | Mean (Standard Deviation) or absolute number | Mean (Standard Deviation) or absolute number | |
Age, years | 73.1 (6.8) | 71.9 (7.1) | 73.6 (6.3) |
Body mass index, kg/m2 | 24.7 (4.4) | 25.4 (3.2) | 24.4 (3.7) |
Gender (female) | 33 | 16 | 17 |
Fall episode within last 1.5 years | 24 | 17 | 7 |
Medical conditions present | |||
- neoplasms | 3 | 2 | 1 |
- endocrine, nutritional and metabolic | 11 | 3 | 8 |
- nervous system | 3 | 2 | 1 |
- eye | 3 | 0 | 3 |
- blood and circulatory system | 15 | 9 | 6 |
- musculo-skeletal system | 24 | 11 | 13 |